SEP remedy withdrawal ‘best for innovation’, say US agencies
US agencies responsible for patents and trademarks have withdrawn remedies for standard-essential patents (SEPs) that are subject to voluntary FRAND (fair, reasonable and non-discriminatory) commitments, on the grounds that this “best serves the interests of innovation and competition”.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
12 February 2021 An EU expert group on standard-essential patents has failed to reach a consensus on the future of SEP licensing, drawing criticism from both sides of the debate between SEP owners and implementers.
7 May 2021 Ericsson and Samsung have agreed a cross-licensing deal which will end all outstanding patent litigation between them over cellular technologies.